A Study to Investigate Tolerability and Efficacy of Asciminib (Oral) Versus Nilotinib (Oral) in Adult Participants ( ≥18 Years of Age) With Newly Diagnosed Philadelphia Chromosome Positive Chronic Myelogenous Leukemia in Chronic Phase (Ph+ CML-CP)
Condition: Philadelphia Chromosome-Positive Chronic Myeloid Leukemia Interventions: Drug: Asciminib; Drug: Nilotinib Sponsor: Novartis Pharmaceuticals Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 13, 2022 Category: Research Source Type: clinical trials
Study to Evaluate Chronic Myeloid Leukemia Treatment Landscape and Real-life Treatment Outcomes in Hungary: Analysis of National Health Insurance Fund Database
Condition: Chronic Myeloid Leukaemia Interventions: Drug: Bosutinib; Drug: Imatinib; Drug: Nilotinib; Drug: Dasatinib; Drug: Ponatinib Sponsor: Pfizer Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 18, 2022 Category: Research Source Type: clinical trials
